S&P 500   4,282.37 (+1.45%)
DOW   33,762.76 (+2.12%)
QQQ   354.65 (+0.75%)
AAPL   180.95 (+0.48%)
MSFT   335.40 (+0.85%)
META   272.61 (+0.00%)
GOOGL   124.67 (+0.77%)
AMZN   124.25 (+1.21%)
TSLA   213.97 (+3.11%)
NVDA   393.27 (-1.11%)
NIO   7.56 (+0.27%)
BABA   84.26 (+1.52%)
AMD   117.86 (-1.35%)
T   15.21 (-3.86%)
F   12.38 (+2.23%)
MU   69.17 (+0.12%)
CGC   0.83 (-1.20%)
GE   105.79 (+1.07%)
DIS   90.77 (+2.46%)
AMC   4.56 (+0.00%)
PFE   38.35 (+0.87%)
PYPL   63.96 (+1.44%)
NFLX   400.47 (-0.66%)
S&P 500   4,282.37 (+1.45%)
DOW   33,762.76 (+2.12%)
QQQ   354.65 (+0.75%)
AAPL   180.95 (+0.48%)
MSFT   335.40 (+0.85%)
META   272.61 (+0.00%)
GOOGL   124.67 (+0.77%)
AMZN   124.25 (+1.21%)
TSLA   213.97 (+3.11%)
NVDA   393.27 (-1.11%)
NIO   7.56 (+0.27%)
BABA   84.26 (+1.52%)
AMD   117.86 (-1.35%)
T   15.21 (-3.86%)
F   12.38 (+2.23%)
MU   69.17 (+0.12%)
CGC   0.83 (-1.20%)
GE   105.79 (+1.07%)
DIS   90.77 (+2.46%)
AMC   4.56 (+0.00%)
PFE   38.35 (+0.87%)
PYPL   63.96 (+1.44%)
NFLX   400.47 (-0.66%)
S&P 500   4,282.37 (+1.45%)
DOW   33,762.76 (+2.12%)
QQQ   354.65 (+0.75%)
AAPL   180.95 (+0.48%)
MSFT   335.40 (+0.85%)
META   272.61 (+0.00%)
GOOGL   124.67 (+0.77%)
AMZN   124.25 (+1.21%)
TSLA   213.97 (+3.11%)
NVDA   393.27 (-1.11%)
NIO   7.56 (+0.27%)
BABA   84.26 (+1.52%)
AMD   117.86 (-1.35%)
T   15.21 (-3.86%)
F   12.38 (+2.23%)
MU   69.17 (+0.12%)
CGC   0.83 (-1.20%)
GE   105.79 (+1.07%)
DIS   90.77 (+2.46%)
AMC   4.56 (+0.00%)
PFE   38.35 (+0.87%)
PYPL   63.96 (+1.44%)
NFLX   400.47 (-0.66%)
S&P 500   4,282.37 (+1.45%)
DOW   33,762.76 (+2.12%)
QQQ   354.65 (+0.75%)
AAPL   180.95 (+0.48%)
MSFT   335.40 (+0.85%)
META   272.61 (+0.00%)
GOOGL   124.67 (+0.77%)
AMZN   124.25 (+1.21%)
TSLA   213.97 (+3.11%)
NVDA   393.27 (-1.11%)
NIO   7.56 (+0.27%)
BABA   84.26 (+1.52%)
AMD   117.86 (-1.35%)
T   15.21 (-3.86%)
F   12.38 (+2.23%)
MU   69.17 (+0.12%)
CGC   0.83 (-1.20%)
GE   105.79 (+1.07%)
DIS   90.77 (+2.46%)
AMC   4.56 (+0.00%)
PFE   38.35 (+0.87%)
PYPL   63.96 (+1.44%)
NFLX   400.47 (-0.66%)
OTCMKTS:ICOTF

iCo Therapeutics (ICOTF) Stock Forecast, Price & News

$0.43
0.00 (0.00%)
(As of 06/2/2023 ET)
Compare
Today's Range
$0.43
$0.46
50-Day Range
$0.27
$0.56
52-Week Range
$0.80
$1.82
Volume
6,086 shs
Average Volume
4,760 shs
Market Capitalization
$3.89 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

ICOTF stock logo

About iCo Therapeutics (OTCMKTS:ICOTF) Stock

Satellos Bioscience, Inc. is a regenerative medicine company, which engages in developing novel therapeutics. It operates through a proprietary technology platform, MyoReGenX™ and Leveraging MyoReGenX™, which identify stem cell based regeneration deficits in muscle diseases and develop therapeutic solutions. The company was founded by Frank Gleeson and Michael Rudnicki in 2018 and is headquartered in Toronto, Canada.

Receive ICOTF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for iCo Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

ICOTF Stock News Headlines

ICO Group Ltd.
[BREAKING] Small Firm Wins $1 Billion Army Contract for Breakthrough "Living Software"
The Washington Post Reports it's: "A revolution in warfare." The Sunday Times Reports it's: "a revolutionary power." Early investors can reap 5,633% gains as England, Germany, Japan and Australia rush to sign contracts. Get the name of the stock here >>>
Satellos Bioscience Inc (MSCL)
Satellos Bioscience GAAP EPS of -C$0.06
[BREAKING] Small Firm Wins $1 Billion Army Contract for Breakthrough "Living Software"
The Washington Post Reports it's: "A revolution in warfare." The Sunday Times Reports it's: "a revolutionary power." Early investors can reap 5,633% gains as England, Germany, Japan and Australia rush to sign contracts. Get the name of the stock here >>>
Satellos Bioscience Announces New Board Appointments
iCo Therapeutics Inc (MSCL)
iCo Therapeutics Inc. V.ICO
iCo Therapeutics Inc. Announces Warrant Exercises
IIROC Trading Halt - ICO
See More Headlines

ICOTF Price History

ICOTF Company Calendar

Today
6/02/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Pharmaceutical Preparations
Sub-Industry
N/A
Sector
Medical
Current Symbol
OTCMKTS:ICOTF
CIK
N/A
Employees
N/A
Year Founded
N/A

Profitability

Net Income
$-1,110,000.00
Pretax Margin
-4,148.78%

Debt

Sales & Book Value

Annual Sales
N/A
Book Value
($0.07) per share

Miscellaneous

Free Float
N/A
Market Cap
$3.89 million
Optionable
Not Optionable
Beta
2.03

Key Executives

  • Frank Gleeson
    President & Chief Executive Officer
  • Warren Whitehead
    Chief Financial Officer
  • Michael Rudnicki
    Chief Scientific Officer
  • J. Robert Hall
    Vice President-Finance & Administration













ICOTF Stock - Frequently Asked Questions

How have ICOTF shares performed in 2023?

iCo Therapeutics' stock was trading at $0.1716 on January 1st, 2023. Since then, ICOTF shares have increased by 150.2% and is now trading at $0.4293.
View the best growth stocks for 2023 here
.

What is iCo Therapeutics' stock symbol?

iCo Therapeutics trades on the OTCMKTS under the ticker symbol "ICOTF."

How do I buy shares of iCo Therapeutics?

Shares of ICOTF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is iCo Therapeutics' stock price today?

One share of ICOTF stock can currently be purchased for approximately $0.43.

How much money does iCo Therapeutics make?

iCo Therapeutics (OTCMKTS:ICOTF) has a market capitalization of $3.89 million. The biotechnology company earns $-1,110,000.00 in net income (profit) each year or ($0.40) on an earnings per share basis.

How can I contact iCo Therapeutics?

iCo Therapeutics' mailing address is 777 Hornby Street 6th Floor, Vancouver A1, V6Z 2T3. The official website for the company is www.icotherapeutics.com. The biotechnology company can be reached via phone at (905) 336-6128, via email at liggett@icotherapeutics.com, or via fax at 604-602-9699.

This page (OTCMKTS:ICOTF) was last updated on 6/2/2023 by MarketBeat.com Staff

My Account -